Recently FDA-approved treatments work to clear clumps of the protein amyloid beta in the brain. A drug that instead goes after tangles of the protein tau can yield similar cognitive outcomes, a new st ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results